Loading stock data…
$8.07+0.37 (+4.81%)
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide.
Rockwell Medical, Inc. in the Healthcare sector is trading at $8.07 with a market capitalization of $32M. Wall Street consensus targets $20.00 (2 analysts), implying a +147.8% move over the next 12 months. The stock is currently 37% below its 52-week high of $12.90, remaining 3.4% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $17.78M↑ | $17.34M↓ | $18.35M↑ | $15.93M↓ | $16.07M |
| Gross Profit | $3.24M↑ | $2.90M↓ | $3.88M↑ | $2.27M↓ | $2.50M |
| Operating Income | -$1.06M↑ | -$1.48M↓ | -$398,000↑ | -$1.58M↓ | -$1.35M |
| Net Income | -$1.17M↑ | -$1.60M↓ | -$554,000↑ | -$1.75M↓ | -$1.49M |
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-s...